Arthritis & rheumatology (Hoboken, N.J.)
-
Arthritis Rheumatol · Sep 2014
Randomized Controlled Trial Multicenter StudyRandomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.
To assess the efficacy and safety of rilonacept, an interleukin-1 inhibitor, in a randomized, double-blind, placebo-controlled trial. ⋯ Rilonacept was generally well tolerated and demonstrated efficacy in active systemic JIA.